Mechanical loading and cv-adrenergic receptor stimulation have both been shown to induce hypertrophy in isolated neonatal heart cells. The present study examined the effects of adrenergic hormones and contractile activity on the hypertrophic response in isolated adult feline cardiomyocytes maintained for more than 14 days in insulin-and serum-supplemented medium. Measurements of the hypertrophic response included cell size, total protein content, myosin heavy chain content, and the time course of activation of increased protein synthesis. Reactivation of the "fetal" gene program was evaluated by secretion of atrial natriuretic factor (ANF) into the medium. Significant myocyte hypertrophy was induced in both quiescent myocytes treated with a1-adrenergic agonists and in beating myocytes treated with f3-adrenergic agonists. However, there were both quantitative and qualitative differences in the response to each type of stimulation. ca-Adrenergic agonists promoted an increase in cell size, protein content, and ANF secretion but not myofibrillar reorganization, which was observed only in beating myocytes. In contrast to results reported for neonatal heart cells, determinants of hypertrophy in beating myocytes exceeded those in nonbeating al-adrenergic agonist-treated heart cells in every parameter examined. In addition, in the case of both beating and cv-adrenergic stimulation, there were marked time-dependent variations in rates of protein synthesis over the interval of 4 hours to 7 days of treatment with each type of stimulus. Differences were also encountered in correlations between rates of protein synthesis and protein accumulation over this interval. The effect of beating was particularly important both to the reorganization of myofibrillar structure and the metabolism of myosin heavy chain. In cultures in which beating was inhibited with the calcium channel antagonist nifedipine, the loss of myosin heavy chain was significantly greater than that of total protein.
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Mechanical loading and cv-adrenergic receptor stimulation have both been shown to induce hypertrophy in isolated neonatal heart cells. The present study examined the effects of adrenergic hormones and contractile activity on the hypertrophic response in isolated adult feline cardiomyocytes maintained for more than 14 days in insulin-and serum-supplemented medium. Measurements of the hypertrophic response included cell size, total protein content, myosin heavy chain content, and the time course of activation of increased protein synthesis. Reactivation of the "fetal" gene program was evaluated by secretion of atrial natriuretic factor (ANF) into the medium. Significant myocyte hypertrophy was induced in both quiescent myocytes treated with a1-adrenergic agonists and in beating myocytes treated with f3-adrenergic agonists. However, there were both quantitative and qualitative differences in the response to each type of stimulation. ca-Adrenergic agonists promoted an increase in cell size, protein content, and ANF secretion but not myofibrillar reorganization, which was observed only in beating myocytes. In contrast to results reported for neonatal heart cells, determinants of hypertrophy in beating myocytes exceeded those in nonbeating al-adrenergic agonist-treated heart cells in every parameter examined. In addition, in the case of both beating and cv-adrenergic stimulation, there were marked time-dependent variations in rates of protein synthesis over the interval of 4 hours to 7 days of treatment with each type of stimulus. Differences were also encountered in correlations between rates of protein synthesis and protein accumulation over this interval. The effect of beating was particularly important both to the reorganization of myofibrillar structure and the metabolism of myosin heavy chain. In cultures in which beating was inhibited with the calcium channel antagonist nifedipine, the loss of myosin heavy chain was significantly greater than that of total protein. (Circ Res. 1993 ;73:1163-1176.) KEY WoRDS * adult heart cells * protein synthesis * atrial natriuretic factor * adrenergic hormones Signal mechanisms involved in the hypertrophy of isolated neonatal heart cells have been characterized in a number of studies. Two significant factors in this response appear to be adrenergic hormones and mechanical loading, either in the form of passive stretch or active development of isometric tension. Hypertrophy resulting from adrenergic receptor stimulation is characterized by (1) upregulation of immediate-early response genes, including c-myc, c-fos, c-jun, and Egr-1,"2 (2) reexpression of fetal proteins and isoforms, such as skeletal a-actin,3,4 13-myosin heavy chain,5 and atrial natriuretic factor (ANF) mRNA and secreted peptide,6 (3) increased levels of myofibrillar proteins5-8 and protein synthesis rates,9-1' and ultimately (4) an increase in myocyte size'10 2 and protein content.5"12 Adrenergic hormone-induced hypertrophy appears to result primarily from a,-adrenergic receptor stimulation,13 although many of the characteristic responses may also be elicited after upregulation of a-adrenergic pathway intermediates such as protein kinase C with phorbol esters or the vasoactive peptide endothelin 1.7,8 Adrenergic-induced cardiomyocyte hypertrophy is significantly modulated by both serum'2'415 and, to some extent, cell density.3"16 Serum alone can also induce a hypertrophic response in neonatal heart cells, which in many respects is similar to that observed with a-adrenergic agonists.",2"14 Although the a,-adrenergic response is independent of cell loading,10 active or passive loading in itself, in the form of beating or stretching of neonatal myocytes, also generates many of the characteristics of hypertrophy, including an immediate-early gene response,17'8 fetal isoform reexpression,171'9 an increase in cell size/protein,'15'1820 and increased contractile protein synthesis.1 18, 20 Equally important, however, is that active arrest of myocyte contractions using high-KCl membrane depolarization or calcium channel blockade induces a rapid loss of myofibril proteins and mRNA from the cardiomyocyte. '6'20'2' In the intact heart, hemodynamic loading represents a predominant factor both in the stimulation of heart growth22-25 and in the prevention of atrophy.26'27 Although load-induced hypertrophy appears to be independent of both a-and /3-adrenergic activation,28 both types of adrenergic agonists also have been shown to produce "load-independent" hypertrophy in the intact heart. 29 Nevertheless, it is difficult to isolate loadand hormone-induced effects in the intact animal, since a-and /-adrenergic agonists both have direct effects on cardiac contractility30 and peripheral vascular tone. 29 Evaluation of the hypertrophic response in isolated adult cardiomyocytes could in part overcome this difficulty in much the same way as have studies in isolated neonatal cells. In response to a-and/or /3-adrenergic agonist stimulation, isolated adult cardiomyocytes display an upregulation of genes for fetal protein iso-forms31,32 and an increase in protein synthesis and content. [32] [33] [34] [35] [36] In each of these studies, hormonal action could clearly be distinguished from loading, since the adult cardiomyocyte preparations were quiescent. Even treatment with f3-adrenergic agonists, which have powerful inotropic and chronotropic effects on the intact heart and isolated neonatal heart cells, failed to stimulate a contractile response in cultured adult rabbit36 and rat32,33 heart cells. Nevertheless, although isolated adult feline cardiomyocytes are also quiescent in culture, they respond to /3-adrenergic stimulation with either altered contractile properties37'38 or an activation of spontaneous contractile activity.3940 Activation of spontaneous contractile activity, even after culture for as long as 3 weeks in the quiescent state,40 suggests that in the adult feline cardiomyocyte model adrenergic receptor responsiveness, membrane excitability, excitation-contraction coupling, and a functional contractile apparatus are preserved. The availability of this model provided an opportunity to directly assess the effect of contractile loading in isolated adult cardiomyocytes and to compare the hypertrophic response to adrenergic agonists in both beating and nonbeating adult heart cells. Additional reasons for evaluation of both signal mechanisms and the hypertrophic response in isolated adult cardiomyocytes would be to compare these results with observations from both neonatal heart cells and the intact heart. There are a number of reasons to suspect that differences may be detected in the response of adult and neonatal heart cells, since it is known that (1) there are differences in a-adrenergic receptor density on cardiomyocytes at different ages,374' (2) there are large differences in protein metabolic rate processes between neonatal and adult heart cells,4243 and (3) there are differences in both the induction of cardiac hypertrophy and activation of immediate-early response genes after aortic coarctation in rats of different ages. 44 For these reasons, the present study was undertaken to more fully characterize adrenergic-induced hypertrophy in isolated adult cardiomyocytes and to address the following questions: Is the hypertrophic response of isolated adult cardiomyocytes after the application of aand 83-adrenergic agonists similar to that in isolated neonatal heart cells with respect to cell growth, stimulation of protein synthesis, and upregulation of "fetal" proteins such as ANF? How does contractile activity influence the hypertrophic response? How does serum influence the hypertrophic response, and is the adrenergic hormone response altered in the presence of serum? Since the overall rate of protein metabolism in adult heart cells is significantly slower than in neonatal cells,42 does this affect the response times to agonist stimulation? And finally, since prolonged exposure to ,3-adrenergic agonists has been shown to produce coordinate downregulation of both 8-adrenergic receptors and calcium channels,45 could this be reconciled with channel blockade in the hypertrophic response in adult cardiomyocytes?
Materials and Methods

Culture Procedures
Adult feline cardiomyocytes were enzymatically dissociated and placed in culture according to procedures described in Clark et al. 40 Cardiomyocytes were allowed to attach to laminin-coated six-well (35or 60-mm) culture dishes in serum-free minimum essential medium (MEM) for 1 hour. Cultures were then gently rinsed in fresh medium, and the medium was replaced with MEM containing 5% fetal bovine serum (Whittaker Bioproducts, Walkersville, Md), 5% NU-Serum (Collaborative Research, Bedford, Mass), and ITS (2.5 ,ug/mL insulin, 2.5 ,g/mL transferrin, and 2.5 ng/mL selenous acid; Collaborative Research). Cytosine arabinoside (10 ,mol/L, Sigma Chemical Co, St Louis, Mo) was also included in the culture medium to prevent fibroblast overgrowth.40 Since both insulin35 and serum'4'534 appear to be required for maximal growth in vitro, the present studies were conducted in the presence of both insulin and serum supplements.
Cultures maintained under serum-free conditions were maintained in medium 199 rather than MEM; medium 199 contained the same supplements as standard medium with the exception that 1 mg/mL bovine serum albumin (BSA, Pentex Inc, Kankakee, Ill) was substituted for the fetal bovine serum and NU-Serum supplements. Serum-free cultures were plated and maintained in this medium without exposure to serum supplements at any time. All cultures were maintained for at least 7 days before initiation of agonist or antagonist treatment. When variable treatment periods were used, agonists or antagonists were added to the cultures at staggered intervals. Cultures were harvested for analysis on either day 14 or day 21 in vitro.
Assessment of Cardiomyocyte Growth
Cell size. Total protein content, myosin heavy chain (HC) content, and cardiomyocyte size were determined in cultures that were harvested after four rinses in phosphate-buffered saline (PBS) and 5 minutes of fixation in 50% methanol-acetone at -20°C. Fixed culture dishes were then stored at -20°C in 100% methanol until assayed for antimyosin binding or total protein or histological staining. Morphological characterization and estimation of cardiomyocyte cell size was determined in cultures stained with monoclonal antimyosin using the Vectastain ABC peroxidase procedure (Vector Laboratories, Inc, Burlingame, Calif). Nuclear staining was achieved by counterstaining cultures with Giemsa. Cell size was estimated using light-microscopic point counting as previously described.40 Cell size is reported as cytoplasmic area per myocyte nucleus. Note, however, that it has been previously determined that 86% of adult feline cardiomyocytes are binucleate.40 For statistical comparisons, the data in each group were weighted by the number of myocyte nuclei in each sample.
Determination of protein. Total protein per culture was determined by two methods after solubilization in 1N NaOH at 60°C for 30 minutes. Direct estimation of long-term effects of both isoproterenol and calcium total protein was conducted using the bicinchoninic acid method46 (BCA, Pierce Chemical Co, Rockford, Ill) calibrated with a BSA standard. Since cultures were grown in the presence of serum on laminin-coated substrates, it was found that a high noncellular protein background could be detected even after extensive prerinses of each culture. Thus, total protein per culture was also assessed in labeling experiments from the incorporation of [14C]leucine into trichloroacetic acid (TCA)-precipitable counts after 7 days of continuous labeling (see below). In both cases, protein results were reported as a change from basal levels in untreated cultures to compensate for the variability of plating efficiency between experiments. 40 Quantitation of myosin HC. Relative amounts of myosin HC per culture were determined by direct binding of monoclonal antimyosin HC using I25I-radiolabeled monoclonal antibody to ventricular myosin HC47 (CCM-52). Monoclonal IgG was prelabeled with NaI125 24 hours before conducting a binding assay using the lactoperoxidase procedure.47 To maintain constant antimyosin concentrations and specific radioactivities in different experiments, the specific radioactivity of the freshly iodinated antibody was adjusted to 1 x 104 cpm/,g antibody by addition of unlabeled monoclonal antibody. The antibody was then diluted into a 0.1% solution of BSA (to prevent nonspecific binding) prepared in borate-buffered saline (50 mmol/L boric acid/ borax and 75 mmol/L NaCl, pH 8.4). The final radiolabeled antibody stock contained 10 ,ug/mL monoclonal antimyosin IgG, at an activity of 1 x 105 cpm/mL. Antibody binding was conducted on methanol-acetone-fixed plates that had been rinsed five times in PBS and treated for 10 minutes in 0.1% BSA in PBS.
One-half milliliter of 1251-labeled antibody stock in 0.1% BSA was added to each well, and the cultures were placed on a rocking table for 30 minutes at room temperature. The labeling solution was removed, and the wells were rinsed four times in distilled water. Total protein was solubilized in NaOH as described above, and the NaOH solution was transferred to a 12 x 75-mm tube along with two 1-mL rinses in 2% carbonate buffer. Total bound 1251 in counts per minute per well was determined by counting for 2 minutes in an LKB 1275 gamma counter. After counting, total protein per tube was determined using the BCA assay.
Determination of Fractional Protein Synthesis Rates
Fractional rates of total protein synthesis and the relative change in total protein synthesis after the initiation of agonists were determined in 14-day cultures using a dual isotopic labeling procedure.48 With this approach, a 7-day prelabel (from days 7 to 14) was used in 0.1 ,Ci/mL of L-[U-14C]leucine (Amersham Inc, Arlington Heights, Ill) to achieve a long-term (but nonequilibrated) protein label. Medium was replaced daily with fresh labeling medium during prelabeling. Immediately before harvesting on day 14, the cultures were pulse-labeled for 4 hours in 2.5 ,uCi/mL of L- [4,5- 3H]leucine in the presence of the [14C]Ieucine label. The long-term label provided an internal reference for total protein content; the pulse-label provided a measure of the instantaneous rate of synthesis during the pulse. 48'49 Relative differences in rates of protein synthesis during the pulse were determined by comparison of the pulse the basal ratio in untreated cultures. Hormonal agonists and antagonists were given for various times during the prelabeling period. After harvesting, 3H to 14C isotope ratios were determined in TCA-precipitated total cell protein and in free leucine isolated from the culture medium by thin-layer chromatography.42 If homogeneity of protein turnover pools was assumed, then an estimate of absolute fractional synthetic rates could be determined using the ratio method originally described by Zilversmit,50 as modified by Clark.48 cAMP Assay cAMP assays were conducted on cultures of adult heart cells, which were established and maintained in 35-mm culture dishes for 7 days. Cultures were treated with isoproterenol or forskolin for the times and doses given in "Results." Fifteen minutes before harvesting cultures, each culture (both control and experimental) was treated with the phosphodiesterase inhibitor 1-methyl-3-isobutylxanthine (IBMX) at lx10-5 mol/L to stabilize cAMP levels. Cultures were then harvested by aspirating the culture medium, rapidly rinsing twice in PBS containing 0.1 mmol/L propranolol, and fixing in 6% TCA at 4°C. Plates were stored at -20°C until assayed. After thawing the TCA, supernatant was collected and centrifuged for 10 minutes at 2000g. The TCA supernatant was collected and extracted twice with ether. After ether extraction, the aqueous phase was lyophilized in a Speed-Vac (Savant Instrument Co). cAMP in lyophilized samples was determined using the cAMP[1251] Assay System (Amersham) according to the manufacturer's instructions. Total protein per culture was determined from the TCA-precipitated cell fraction as described above.
ANF Assay
Immunoreactive ANF in medium samples was determined by radioimmunoassay. Cultures were established in 35-mm six-well culture dishes in complete culture medium. Agonists were applied for various periods beginning on day 9 in vitro. On day 11, the medium in all cultures was changed to serum-free ANF collection medium consisting of MEM containing 0.3 mg/mL BSA, ITS, glutamine, and 50 ,ug/mL D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (Calbiochem Co, La Jolla, Calif), with or without agonists. On day 12, the medium was removed and replaced with 0.75 mL per culture of the same medium for a timed 48-hour collection (days 12 to 14). Previous studies have shown that ANF secreted into serum-free medium is stable and maximal over 48 hours of collection.6 For studies in which the time course of agonist treatment was less than 48 hours, the procedure followed was the same as above, with the exception that agonists were added to the serum-free collection medium for the shorter interval before harvesting the medium. After collection, the medium was quick-frozen and lyophilized in a Speed-Vac. Immunoreactive ANF was determined in each sample using a rat ANF radioimmunoassay kit (Peninsula Laboratories, Belmont, Calif). Lyophilized samples were resuspended in 0.1 mL assay buffer, and duplicate aliquots were assayed for each sample. Interassay and intra-assay variability were 8.4% and 9.2%, respectively. to continuous label ratio in agonist-treated cultures with
The lowest level of ANF detectable in this assay was 20 pg/mL. The rat anti-ANF antibody cross-reacted 100% with canine and human a-ANF.
Statistical Methods
In the present study, data are reported both as absolute values and as percent change from basal levels in untreated control cultures. In comparing absolute values, data were analyzed by one-way ANOVA. After ANOVA including Levene's test for homogeneity of variances, a multiple group comparison test (Student-Newman-Keuls) or a direct comparison with basal values using a two-tailed t test with separate variances was performed. In cases in which data were reported as a percent change from basal levels, ANOVA was performed on ranked data. This nonparametric test was used in these cases since data from control (mean, 100%) and treated groups did not have equal variances. A value of Pc.05 was taken as a level of significant difference between two groups. Statistical tests were conducted using the spss/pc+ (SPSS, Chicago, Ill) statistics program.
Results
Cell Growth
Cell size and sarcomere reorganization. In adult feline cardiomyocytes, ,3-adrenergic agonists promote an increase in cell size,40 whereas in neonatal rat cardiomyocytes, this is primarily an a-adrenergic response.'1012 The hypertrophic effects of both a-and ,B-adrenergic agonists on adult feline cardiomyocytes are compared in Fig  IA. Mean cell area per nucleus increased approximately 42% after 7 days in isoproterenol compared with untreated 14-day control cultures. This increase coincided with an activation of beating activity and reorganization of striated myofibrils ( Fig 2B) . A smaller (19%) but statistically significant (P<.01) increase in cell size was also observed after treatment with the a-adrenergic agonist phenylephrine. In the case of phenylephrine, cardiomyocytes remained quiescent and did not undergo significant reorganization of myofibrillar structure ( Fig 2C) . Data from two control experiments are also shown in Fig IA. Treatment of cardiomyocyte cultures with the phosphodiesterase inhibitor IBMX activated contractile activity40 and also induced significant myofibrillar reorganization ( Fig 2D) . However, there was no significant increase in cardiomyocyte cell size after IBMX treatment ( Fig 1A) . Nifedipine, on the other hand, is a calcium L-channel antagonist that totally blocked isoproterenol-induced contractile activity. When contraction was inhibited in isoproterenoltreated cultures with nifedipine, there was no increase in cardiomyocyte size ( Fig 1A) .
The effect of serum on ,3-adrenergic stimulation of cell size is shown in Fig 1B. In the absence of serum, muscle cells remained rodlike and failed to undergo significant spreading on the substratum. Isoproterenol produced a significant increase in cardiomyocyte size and spreading, both in the presence and absence of serum. Serum alone also produced a significant increase in cell size over that observed under serum-free condi- tion of isoproterenol-induced cardiomyocyte hypertrophy was observed in the presence of increasing concentrations of propranolol ( Fig IC) . Total protein and myosin HC. It has been suggested that the increase in cell size of adult cardiomyocytes in the presence of adrenergic agonists is simply the result of cell spreading without true cell growth.39 Cardiomyocyte hypertrophy would be expected to result in not only an increase in protein content per myocyte but also an increase in contractile protein content. Total protein and total myosin HC per culture were assessed in 14and 21-day cultures of adult feline cardiomyocytes after treatment for various periods with isoproterenol ( Fig 3) . Treatment with isoproterenol for 14 days resulted in a gradual increase in both total protein and myosin HC isoproterenol-induced beating with the calcium channel blocker nifedipine also inhibited the increase in cell size. This also appeared to be the case with respect to the accumulation of protein and myosin HC after nifedipine treatment (Fig 4) . However, treatment of nonbeating cells at day 7 in culture with nifedipine had an even more profound effect on myosin HC content than on total protein content. Whereas there was only an 8% to 9% loss in total protein relative to the basal levels after 14 days in nifedipine, there was nearly a 50% loss in antimyosin binding after 14 days in nifedipine compared with quiescent control cultures at 21 days in vitro (Fig 4) . Stimulation of hypertrophy by pretreatment for 5 to 18 days with isoproterenol before the addition of nifedipine did not prevent subsequent atrophy in the calcium channel blocker (Fig 4) . The addition of nifedipine resulted in a rapid and progressive loss of both total protein and myosin HC. As in cultures with nifedipine alone, the loss of myosin HC in the presence of nifedipine and isoproterenol was significantly greater than the loss of total protein (Fig 4) . Protein Synthesis Rates Time course and dose-response relation in ,B-adrenergic agonists. An increase in cell size, total protein, and myosin HC content implies a concurrent increase in Isoproterenol-stimulated increase in total protein and myosin heavy chain (HC) content. Top, Graph shows total protein and myosin HC content in 14-day (control [Ctri] through 7 on abscissa) and 21-day (14 on abscissa) cultures that have been treated for 1 to 14 days in isoproterenol. Total protein was determined by bicinchoninic acid assay. Myosin HC content was determined from binding of 1251-labeled monoclonal antimyosin. Bottom, Bar graph shows the absolute level of antimyosin binding per microgram protein in each culture. *P<.05 vs untreated control cultures. From left to right, n=33, 9, 9, 12, 12, 12, 12, 6, and 9 cultures. protein synthesis to account for new protein appearing in the hypertrophic state. The effect of isoproterenol on total protein synthesis and accumulation is shown in Fig  5. Although isoproterenol resulted in an immediate activation of myocyte beating, there was, nevertheless, a delay of nearly 48 hours before an observed increase in fractional protein synthesis rates (Fig 5, bars) . Synthesis rates subsequently increased to a maximum of 19±1.8% (P<.001, n=27) above basal levels on day 4 in isoproterenol. Elevation of fractional synthesis rates was transient in the presence of isoproterenol, and these rates subsequently returned to the basal level over the 4to 7-day period in agonist. The accumulation of total protein gradually rose in isoproterenol and reached a level approximately 70% above the control level after 5 days in agonist (Fig 5, line) . The dose-response relation of isoproterenol-stimulated protein synthesis at 4 days in agonist is shown in the Fig 5 inset .
Comparison ofprotein synthesis in a-and /-adrenergic agonists. In neonatal rat heart cultures, a significant difference in the effect of a-and 18-adrenergic agonists on protein synthesis has been observed.9 The change in protein synthesis and accumulation after isoproterenol, phenylephrine, and norepinephrine treatment are shown in Fig 6. During 4 hours of exposure to phenylephrine, there was no change in protein synthesis. However, a significant decrease in synthesis was observed over this period after exposure to isoproterenol and to norepinephrine. By 24 hours, protein synthesis /TotaI Protein * Nifedip+ fednen 7 14 0 4 6 9 Time in Nifedipine (days) FIG 4 . Bar graph showing the effect of nifedipine and isoproterenol (Iso) plus nifedipine on total protein and myosin heavy chain (HC) content in 14- and 21-day cultures of adult cardiomyocytes. The first two pairs of bars on the left were derived from cultures that had been maintained in nifedipine from day 7 until harvesting on day 14 or day 21. The four sets of bars on the right represent cultures that have been treated with Iso from day 7 until harvesting on day 21. During the last 4, 6, or 9 days before harvesting, nifedipine was also added to the medium to assess the reversal of beating-induced hypertrophy after contraction blockade. *P<.05 vs untreated control cultures (n=6 to 9 cultures in each analysis). was elevated in phenylephrine, whereas in both isoproterenol and norepinephrine, a recovery from the initial suppression of protein synthesis was observed. After 4 days in agonists, the levels of protein synthesis were significantly greater than basal levels in all groups. After 7 days, elevated fractional synthesis rates were main- TREATMENT tained in phenylephrineand norepinephrine-treated cultures, whereas the rates in isoproterenol-treated cultures had returned to basal levels. Data given in Table 1 compare the fractional synthesis rate and the net rate of total protein synthesis in these cultures. As indicated in Fig 6 , the fractional synthesis rates show both transient increases and decreases from basal levels over different periods in agonists. However, the net level of protein synthesis rises steadily in all agonists. This increase primarily reflects the influence of an increase in cell mass on net protein synthesis. The change in protein mass per culture is also shown in Fig 6. In both isoproterenol and norepinephrine, a gradual rise in protein content that reached significant levels by day 4 was seen. A smaller increase in protein content was observed in phenylephrine. When total protein was compared in cultures treated with either isoproterenol or phenylephrine for 4 or more days, the differences in protein accumulation were significant. Protein content in isoproterenol had increased to 149.5+7.6% (n=52) of the control levels, whereas protein content in phenylephrine rose to only 121.8+8.3% (n= 17). A t test indicated a significant difference between these two treatments (P=.018). However, there was no difference in fractional synthesis rates over this same interval (isoproterenol, 26.3+0.8% per day; phenylephrine, 26 .2+1.1% per day; P=0.93).
Effect ofserum. The presence of serum in the medium has been shown to significantly attenuate a-adrenergicinduced protein synthesis in neonatal10 and adult34 cardiomyocytes. The effect of serum on both a-and ,B-adrenergic-induced protein synthesis and accumulation is shown in Table 2 . As in the presence of serum, there was an elevation in both fractional synthesis rates and protein accumulation after isoproterenol and phenylephrine. Phenylephrine appeared to have somewhat greater influence on protein accumulation in serum-free medium compared with its effect in the presence of serum. Fractional protein synthesis rates in the presence of serum were nearly 25% greater than under serum-free conditions, with nearly twice the amount of protein per culture. These differences most likely represent different steady-state turnover rates between serum and serum-free conditions, since both types of cultures had been maintained under constant conditions for 14 days before analysis.
Effect ofbeating. To test whether the loss of protein in cultures treated with calcium channel blocker was related to effects on protein synthesis, protein synthesis and accumulation were evaluated in cultures treated with nifedipine with or without isoproterenol. The results given in Table 3 show that nifedipine significantly depressed protein synthesis and caused a progressive loss in total protein content. It was notable that Values are mean±SEM. Fractional rates of protein synthesis were calculated from the ratios of 4-hour and 7-day leucine label incorporation as described in "Materials and Methods." Net protein synthesis rates were calculated from the product of the protein content per culture and the fractional rate. *P<.05 and tP<.005 by ANOVA, contrasting each group with the basal level in control cultures using a two-tailed t test with separate variances. the combination of nifedipine and isoproterenol had a more significant catabolic effect than the effect of nifedipine alone. It also appeared that the protein turnover rate in isoproterenol plus nifedipine represented a new steady state, since the fractional synthesis remained relatively constant at 10% to 12% per day for 1 to 7 days in these agents.
Isoproterenol Stimulation of cAMP
Studies described above suggest that isoproterenol action is through stimulation of the ,3-adrenergic receptor. However, to determine whether there may be receptor downregulation in the continued presence of isoproterenol with a concurrent loss in cellular response, the dose-response relation and time course of The change in fractional rates of protein synthesis and protein content were determined in 14-day cultures of adult feline cardiomyocytes maintained in serum-free medium from the time of plating, with agonists added at the times indicated. FSRs were computed as described in "Materials and Methods." *P<.005 and tP<.05 vs basal levels in serum-free control cultures. Adrenergic Effect on ANF Synthesis ANF expression in myocardial hypertrophy represents the reexpression of the "fetal" gene program. Increased synthesis of ANF in the ventricle25.5' and in isolated ventricular cardiomyocytes651-53 has been observed after hypertrophic stimuli. ANF secretion was determined in feline cardiomyocytes maintained in culture for 14 days and treated for 0.5 to 5 days with agonist. The data in Fig  9 show that ANF secretion was more than nine times greater in cells treated with isoproterenol (1 x 10-5 mol/L) than in untreated control cultures (9.4+1.0, P<.05 versus control, n=22). A significant but lower During the final 15 minutes before harvesting, 1 x 10-5 mol/L 1-methyl-3-isobutylxanthine was added to retard cAMP degradation. 3+ d indicates combined data from cultures treated between 3 and 5 days in agonist. *P<.05 vs basal level in untreated control cultures (CtrI). From left to right, n=104, 26, 9, 12, 9, 15, 11, and 12 cultures. increase in ANF secretion was also observed after treatment with phenylephrine (4.38±0.09, P<.05 versus control, n= 14). The dose-dependent relation of ANF secretion in response to isoproterenol and phenylephrine is also shown in Fig 9. ANF secretion was stimulated at 1 x 10`mol/L isoproterenol and peaked at 1 x 10-5 mol/L, whereas maximal secretion in response to phenylephrine occurred at lXlO-5 to lX 10-4 mol/L. Timecourse studies in Fig 10 Days in Agonist FIG 10 . Time course of immunoreactive atrial natriuretic factor (i.r. ANF) secretion into culture medium of 14-day cultures of adult cardiomyocytes after treatment with aand 3-adrenergic agonists. Data represent the accumulation of ANF into the medium during the final 48 hours of agonist treatment or for the shorter period, when agonist treatment was less than 48 hours. Isoproterenol was applied at 1 x 10-5 mol/L, and phenylephrine was applied at 1 x 10-4 mol/L. *P<.05 vs untreated basal level of ANF secretion into the medium. From left to right, n=27 untreated cultures, n=7, 8, 2, 12, and 8 cultures in isoproterenol, and n=2, 2, 3, 9, and 2 cultures in phenylephrine.
response is more rapid in isoproterenol than in phenylephrine (2 versus 4 days).
Discussion
The present study has examined and compared characteristics of a-and ,B-adrenergic agonists as well as the effect of beating on the hypertrophic response in isolated adult feline cardiomyocytes in long-term culture. Measures of hypertrophy included an estimation of cardiomyocyte size, protein content, myosin HC content, and protein synthesis rates. An additional factor related to ventricular myocyte hypertrophy is the reexpression of "fetal" proteins, which was characterized in the present study by evaluation of ANF release. The general conclusions derived from these studies are as follows: (1) Although both a-and f3-adrenergic agonists stimulate a hypertrophic response in cultured adult cardiomyocytes, there are both quantitative and qualitative differences in the response to each type of agonist. (2) The response in adult cardiomyocytes after both adrenergicand load-induced hypertrophy differs from that in cultured neonatal heart cells in a number of respects. (3) ,B-Adrenergic effects appear to derive primarily from activation of cardiomyocyte contractile activity. Inhibition of beating in the presence of isoproterenol also abolishes the hypertrophic response. (4) Qualitatively similar results are observed after adrenergic agonist stimulation both in serum-free medium and in the presence of serum. (5) Hypertrophic responses related to both adrenergic receptor stimulation and beating show significant variation over time.
Response to a-and /-Adrenergic Agonists
The a-adrenergic response may be clearly distinguished from the effects of contractile activity in the cD 0 present study, since myocytes remained quiescent in the presence of either phenylephrine or norepinephrine plus propanolol. Nevertheless, a-adrenergic receptor stimulation resulted in a significant increase in cell size, protein content, protein synthesis rates, and ANF synthesis. The response to phenylephrine differed from that in neonatal heart cells in two respects. First, unlike the observation by Iwaki et al,' phenylephrine did not appear to promote increased myofibrillar organization into sarcomeric units (Fig 2C) . This may be due to different effects of phenylephrine on contractility in adult and neonatal heart cells. In adult feline cardiomyocytes, sarcomere reorganization has only been observed after treatments that activate beating, which, in addition to those shown in Fig 2, include forskolin and field stimulation (authors' unpublished observations). A second difference between the response of neonatal and adult cardiomyocytes to phenylephrine is in the time course of phenylephrine stimulation of ANF secretion. Phenylephrine treatment of neonatal heart cells induced maximal ANF secretion by 24 to 36 hours.6'53 In adult myocytes, at least 96 hours in phenylephrine was required for maximal ANF secretion. The responses of neonatal and adult cardiomyocytes to a-adrenergic agonists were similar in that in both cell types there was a significant increase in cell size, protein synthesis rates, and upregulation of ANF secretion. ,3-Adrenergic stimulation of neonatal cardiac myocytes neither activated the transcription of either Egr-1 or c-myc immediate-early response genes"2 nor stimulated protein synthesis rates9 nor induced ANF secretion.654 However, isoproterenol did have some hypertrophic effects in neonatal rat heart cells in stimulating an increase in cell size and promoting sarcomeric reorganization,1 as well as upregulating the transcription of c-fos and c-jun mRNA.' In the present study, isoproterenol represented a potent stimulus for increasing cell size, protein content, myosin HC content, protein synthesis rates, sarcomeric reorganization, and ANF secretion in isolated adult cardiomyocytes. Isoproterenol appeared to have a greater effect on these parameters of myocyte hypertrophy than did phenylephrine. The mechanism of action of isoproterenol appeared to be through 8-adrenergic receptor action, since it could be inhibited with propranolol and resulted in an increase in intracellular cAMP levels. cAMP production was maintained at levels that were statistically greater than basal levels for at least 2 days in the presence of 1 x 10-5 mol/L isoproterenol.
Effect of Beating
The immediate response to isoproterenol was elevation of cAMP levels and an activation of cardiomyocyte beating.40 Thus, it was not possible to clearly distinguish hypertrophy resulting from f3-adrenergic receptor stimulation from that which may result from the activation of cell beating. Both active and passive loading have been implicated as signal events in the hypertrophy of cardiomyocytes in vitro. Activation of beating in low KCI medium1""15,20,39 or by direct field stimulation,55'56 as well as passive loading in the form of myocyte deformation on stretchable membranes,17-19,57 also activates hypertrophic response signals and promotes increased protein synthesis and cell enlargement. These studies the induction of cardiomyocyte hypertrophy. In studies using contraction blockade, total and contractile protein synthesis and content were depressed.'6'20'2' The effect on myosin HC mRNA levels and synthesis was especially pronounced16'2' and most probably accounted for the significant loss of myosin HC in both neonatal21 and adult40 cardiomyocytes, as was also found in the present study (Fig 4) .
In the studies of both Decker et al36 and Pinson et al,32 a significant increase in protein synthesis rates was observed in isolated adult cardiomyocytes after treatment with ,3-adrenergic agonists in the absence of contractile activity. These results suggest that f3-adrenergic agonists can directly influence protein synthesis rates independent of their effect on beating. However, it also points to a difference between beating and 13-adrenergic-induced effects on protein synthesis, since the initial response to activation of beating with isoproterenol was a transient decrease rather than an increase in protein synthesis rates (Fig 6) . Although total protein synthesis rates appeared to have returned to basal levels by 24 hours in isoproterenol, these results do not reflect the fact that there were considerable differences between the rates of synthesis of different myofibrillar proteins at this time. After 24 hours in isoproterenol, the rate of myosin HC synthesis was much less than basal levels, whereas that of actin and other proteins was greater than in control cultures (authors' manuscript in preparation). This response was consistent with the observations of Dubus et al,33who also reported a stimulation of total protein synthesis rates and a depression of myosin HC synthesis 24 hours after treatment with isoproterenol in adult rat cardiomyocytes. However, since that study did not evaluate protein synthesis after longer treatments, it could not be determined whether their result represented only a transient response, as observed in the present study.
To better distinguish the effect of ,B-adrenergic agonists from beating in adult cardiomyocytes, the effect of isoproterenol was also determined in cultures in which beating was inhibited by nifedipine. Under these conditions, isoproterenol had an enhanced and sustained catabolic effect. Both protein synthesis rates and total protein content were more depressed in the presence of isoproterenol and nifedipine than was observed in the presence of nifedipine alone (Fig 4 and Table 3 ).
Effect of Serum
A number of studies involving the development of myocardial hypertrophy in vitro have been conducted on cells maintained in serum-free medium. Simpson et al14 were the first to note that substantial hypertrophy occurred in neonatal rat cardiomyocytes with the addition of serum to the medium. Serum also promotes spontaneous beating in neonatal rat cardiomyocytes, which is not usually observed in low-density serum-free cultures. Serum growth factors, fibroblast growth factors, and transforming growth factor-,B have also been implicated in regulation of the myocardial gene expression related to the hypertrophic response.58 In the adult cardiomyocyte, serum and serum growth factors have been shown to have profound effects on morphology, growth, and in some cases survival in culture.59'60 A very significant issue related to the use of serum in studies of strongly implicate a load-dependent signal pathway in the hypertrophic response in either neonatal or adult cardiomyocytes was raised in the study of Bishopric and Kedes.3 It was found that the combination of serum and cell density affected not only the magnitude of the cardiomyocyte response to a-and 83-adrenergic agonists but might also change the nature of the response. At low cell density in serum-free medium, induction of transcription for skeletal a-actin occurred primarily in response to a-adrenergic agonists. However, at higher cell densities and in the presence of serum, this response was induced primarily by fB-adrenergic agonists.3 In the present study, serum did not appear to change the nature of the hypertrophic response to a-and 3-adrenergic agonists, although it did affect the rate and ultimate magnitude of the hypertrophic response ( Fig 1B  and Table 2 ).
Protein Synthesis/Accumulation
Changes and differences in the time course of rates of protein synthesis and accumulation after a-and ,B-adrenergic agonist-induced stimulation of protein synthesis most likely represent regulation of processes at a number of levels that influence net rates of protein synthesis. These different levels of regulation may include increased message availability and/or changes in message half-life, changes in rates of initiation of message translation and peptide elongation,6' increased protein synthetic capacity,1162 changes in posttranslational processing,48 and changes in rates of protein degradation.2' Different effects of a-and ,B-adrenergic agonists at any level of this process could be reflected in changes in the rates of amino acid incorporation into proteins and also whether there is a net increase in cardiomyocyte mass and contractile protein content. A major finding of the present study is that beating and adrenergic hormone effects on protein synthesis and accumulation are time-dependent processes. The result from a specific stimulation may appear quite different after different treatment periods. In addition, there is no direct correlation between observed rates of protein synthesis and protein accumulation or cell growth. For example, phenylephrine stimulates a rapid and sustained increase in fractional protein synthesis rates. It does not, however, produce the same level of cell growth (protein accumulation) as observed after isoproterenol, even though the period of elevated protein synthesis in isoproterenol is much more transient than in phenylephrine. This suggests that there are significant differences in how each of these agents influence adult cardiomyocyte growth. The mechanism that accounts for these differences is not clear. However, posttranslational regulation of protein metabolism in adult heart cells48 presents a number of potential sites that may serve as a target for these regulatory mechanisms.
The data in Table 1 compare both fractional and net rates of protein synthesis. Since fractional rates describe proportional rates of addition or replacement of protein per unit time, they provide an absolute reference for comparing protein synthesis in a variety of different conditions or cell types or among different proteins. It is important to note that this rate constant is independent of protein mass. Net protein synthesis, on the other hand, is the product of the fractional rate times the pool size. The increase in cell size and protein mass during hypertrophy dictates that net protein synthesis per highly correlated with net isotope incorporation per culture during the pulse label. Thus, studies that compare net isotope incorporation per culture derive a value proportional to net synthesis rates, but these values are not directly proportional to fractional synthesis rates, as is shown in Table 1 .
Effect of Beating and Adrenergic Agonists on ANF Synthesis
In contrast to the immediate-early gene response, ANF expression represents cardiac-specific upregulation of a "fetal" protein that is normally expressed at very low levels in ventricular myocytes. In vivo, ventricular synthesis of ANF is elevated under a number of conditions, including acute volume expansion, hypertension, and aortic constriction, and after the administration of glucocorticoid, mineralocorticoid, and thyroid hormones. 63 One of the more definitive differences between isolated neonatal and adult cardiomyocytes shown in the present study is the difference in response to beating and adrenergic agonists in the stimulation of ANF secretion. In neonatal heart cells, it has been well documented that ANF synthesis and release is mediated by intracellular calcium regulated both through the calcium-calmodulin branch and the protein kinase C branch6465 as well as by electrical stimulation of contraction.56 Activation of a-adrenergic receptors or activation of protein kinase C results in a significant increase in ANF production.6'64-66 Secretion of ANF from atrial cells occurs more rapidly in response to these agents than from ventricular myocytes because of the regulated secretory pathway. In contrast, a constitutive secretory pathway is used in ventricular myocytes,67 such that increases in ANF secretion occur in concert with increases in ANF mRNA and require time courses of stimulation between 12 and 24 hours. Thus, it is not likely that the calcium transients associated with contraction are primarily responsible for increases in ANF secretion, because studies have shown that 24 hours of treatment with the ionophore A23187 is required for increases in ANF mRNA and ANF secretion in neonatal cardiac myocytes. 66 In spontaneously beating neonatal cells, several studies have shown that /3-adrenergic agonists either do not stimulate ANF synthesis or inhibit secretion. 64, 68 However, beating per se, which has no effect on intracellular cAMP, does seem to affect ANF secretion as electrical pacing of neonatal cells stimulates ANF secretion and mRNA,56 whereas treatment with calcium channel blockers inhibits both processes.64 Contraction does positively modulate ANF production in isolated adult rat atrial cells, but the signaling mechanism involved is not clear. 69 Our studies indicate that, in contrast to neonatal heart cells, both isoproterenol and phenylephrine stimulate ANF secretion above basal levels in adult feline cardiomyocytes, suggesting that signaling pathways mediated by both a-and ,l-adrenergic agonists are operative. Presently, it is not known whether beating is associated with a separate signaling mechanism. It was interesting that the largest activation of ANF synthesis occurred in beating cultures treated with isoproterenol. This contrasts with neonatal atrial cells in which isoproterenol, forskolin, and other agents that increase cAMP actually inhibited phorbol esterculture would increase. Net protein synthesis rates are induced increases in ANF syntheSiS.54 The reason for this difference is not clear but may result in part from differences in the regulation of synthesis and secretion of natriuretic peptides by atrial and ventricular cells.
Conclusions
The central conclusion from the present study is that there are at least two independent pathways leading to hypertrophy in isolated adult feline cardiomyocytes. One pathway is through a-adrenergic receptor stimulation, and the second is controlled through load, as represented in the present study by active beating. The hypertrophic responses following each type of signaling are in some respects similar (increased cell size, protein content, protein synthesis rates, and production of ANF) and in some respects distinct (reorganization of myofibrils, both positive and negative correlations of beating with myosin HC content, different time courses in stimulation of protein synthesis, and regulation of protein metabolism). A further conclusion from these studies is that it is unlikely that regulation of hypertrophy in adult cardiomyocytes from either type of stimulus can result from a single trigger event that activates a long-term programmed gene response. There are significant differences in the time course of each response, especially at the level of protein synthesis, which indicate that this process is controlled through a series of steps that culminate in the generation of increased cardiomyocyte mass. The model of in vitro hypertrophy provided by isolated adult feline cardiomyocytes offers an unparalleled opportunity to further characterize additional aspects of the hypertrophic response as related to loading or hormonal signal events at transcriptional, translational, and posttranslational levels of regulation.
